Long-term survival in patients with post-LVAD right ventricular failure: multi-state modelling with competing outcomes of heart transplant.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
08 2021
Historique:
received: 21 01 2021
revised: 19 04 2021
accepted: 12 05 2021
pubmed: 26 6 2021
medline: 2 2 2022
entrez: 25 6 2021
Statut: ppublish

Résumé

Multicenter data on long term survival following LVAD implantation that make use of contemporary definitions of RV failure are limited. Furthermore, traditional survival analyses censor patients who receive a bridge to heart transplant. Here we compare the outcomes of LVAD patients who develop post-operative RV failure accounting for the transitional probability of receiving an interim heart transplantation. We use a retrospective cohort of LVAD patients sourced from multiple high-volume centers based in the United States. Five- and ten-year survival accounting for transition probabilities of receiving a heart transplant were calculated using a multi-state Aalen Johansen survival model. Of the 897 patients included in the study, 238 (26.5%) developed post-operative RV failure at index hospitalization. At 10 years the probability of death with post-op RV failure was 79.28% vs 61.70% in patients without (HR 2.10; 95% CI 1.72 - 2.57; p = < .001). Though not significant, patients with RV failure were less likely to be bridged to a heart transplant (HR 0.87, p = .4). Once transplanted the risk of death between both patient groups remained equivalent; the probability of death after a heart transplant was 3.97% in those with post-operative RV failure shortly after index LVAD implant, as compared to 14.71% in those without. Long-term durable mechanical circulatory support is associated with significantly higher mortality in patients who develop post-operative RV failure. Improving outcomes may necessitate expeditious bridge to heart transplant wherever appropriate, along with critical reassessment of organ allocation policies.

Sections du résumé

BACKGROUND
Multicenter data on long term survival following LVAD implantation that make use of contemporary definitions of RV failure are limited. Furthermore, traditional survival analyses censor patients who receive a bridge to heart transplant. Here we compare the outcomes of LVAD patients who develop post-operative RV failure accounting for the transitional probability of receiving an interim heart transplantation.
METHODS
We use a retrospective cohort of LVAD patients sourced from multiple high-volume centers based in the United States. Five- and ten-year survival accounting for transition probabilities of receiving a heart transplant were calculated using a multi-state Aalen Johansen survival model.
RESULTS
Of the 897 patients included in the study, 238 (26.5%) developed post-operative RV failure at index hospitalization. At 10 years the probability of death with post-op RV failure was 79.28% vs 61.70% in patients without (HR 2.10; 95% CI 1.72 - 2.57; p = < .001). Though not significant, patients with RV failure were less likely to be bridged to a heart transplant (HR 0.87, p = .4). Once transplanted the risk of death between both patient groups remained equivalent; the probability of death after a heart transplant was 3.97% in those with post-operative RV failure shortly after index LVAD implant, as compared to 14.71% in those without.
CONCLUSIONS AND RELEVANCE
Long-term durable mechanical circulatory support is associated with significantly higher mortality in patients who develop post-operative RV failure. Improving outcomes may necessitate expeditious bridge to heart transplant wherever appropriate, along with critical reassessment of organ allocation policies.

Identifiants

pubmed: 34167863
pii: S1053-2498(21)02316-0
doi: 10.1016/j.healun.2021.05.002
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

778-785

Informations de copyright

Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Auteurs

Rohan Shad (R)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Robyn Fong (R)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Nicolas Quach (N)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Cayley Bowles (C)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Patpilai Kasinpila (P)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Michelle Li (M)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Kate Callon (K)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Miguel Castro (M)

Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart Center, Texas.

Ashrith Guha (A)

Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart Center, Texas.

Erik E Suarez (EE)

Department of Cardiothoracic Surgery, Houston Methodist DeBakey Heart Center, Texas.

Sangjin Lee (S)

Department of Cardiothoracic Surgery, Spectrum Health Grand Rapids Michigan, Michigan.

Stefan Jovinge (S)

Department of Cardiothoracic Surgery, Spectrum Health Grand Rapids Michigan, Michigan.

Theodore Boeve (T)

Department of Cardiothoracic Surgery, Spectrum Health Grand Rapids Michigan, Michigan.

Yasuhiro Shudo (Y)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California.

Curtis P Langlotz (CP)

Stanford Artificial intelligence in Medicine and Imaging Center, Stanford University School of Medicine, Califorina; Department of Radiology, Stanford University School of Medicine, California.

Jeffrey Teuteberg (J)

Stanford Artificial intelligence in Medicine and Imaging Center, Stanford University School of Medicine, Califorina; Department of Cardiovascular Medicine, Stanford University School of Medicine, California.

William Hiesinger (W)

Department of Cardiothoracic Surgery, Stanford University School of Medicine, California; Stanford Artificial intelligence in Medicine and Imaging Center, Stanford University School of Medicine, Califorina. Electronic address: willhies@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH